当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:277.40亿  总市值:277.40亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金13,187,513,851.536,624,771,668.3226,023,017,132.7719,024,372,147.87
  收到其他与经营活动有关的现金395,805,927.41388,569,566.23280,538,285.28324,699,961.01
  经营活动现金流入小计13,583,319,778.947,013,341,234.5526,303,555,418.0519,349,072,108.88
  购买商品、接受劳务支付的现金8,606,990,964.54,146,033,290.8516,142,039,574.3312,039,371,038.9
  支付给职工以及为职工支付的现金2,114,738,745.091,178,161,512.063,913,340,631.953,015,007,149.6
  支付的各项税费858,659,232.5332,149,890.981,363,148,902.841,035,250,760.61
  支付其他与经营活动有关的现金549,371,202.18300,625,302.551,526,578,294.52992,232,141.96
  经营活动现金流出小计12,129,760,144.275,956,969,996.4422,945,107,403.6417,081,861,091.07
  经营活动产生的现金流量净额1,453,559,634.671,056,371,238.113,358,448,014.412,267,211,017.81
二、投资活动产生的现金流量:
  收回投资收到的现金--432,639,550.39432,639,550.39
  取得投资收益收到的现金--13,029,683.1812,813,000
  处置固定资产、无形资产和其他长期资产收回的现金净额2,241,536.661,378,629.4624,180,412.21,562,120.08
  处置子公司及其他营业单位收到的现金净额--1,200,0001,200,000
  收到的其他与投资活动有关的现金11,103,778,541.215,119,787,658.5223,780,824,318.1222,169,996,726.03
  投资活动现金流入小计11,106,020,077.875,121,166,287.9824,251,873,963.8922,618,211,396.5
  购建固定资产、无形资产和其他长期资产支付的现金65,935,054.4513,692,017.78322,916,673.8108,169,339.72
  投资支付的现金1,160,000500,000--
  取得子公司及其他营业单位支付的现金14,709,0002,878,000136,624,098.96120,448,134.62
  支付其他与投资活动有关的现金10,456,500,0005,410,000,00025,218,512,080.0522,752,770,000
  投资活动现金流出小计10,538,304,054.455,427,070,017.7825,678,052,852.8122,981,387,474.34
  投资活动产生的现金流量净额567,716,023.42-305,903,729.8-1,426,178,888.92-363,176,077.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,762,8001,753,000
  其中:子公司吸收少数股东投资收到的现金--1,762,8001,753,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--1,762,8001,753,000
  偿还债务支付的现金--91,429,093.471,429,093.4
  分配股利、利润或偿付利息支付的现金501,024,140.3819,029,494.19927,168,979.77914,684,834.87
  其中:子公司支付给少数股东的股利、利润11,466,378.3810,042,829.8877,862,107.1859,810,385.75
  支付其他与筹资活动有关的现金657,512,668.06309,327,559.791,462,963,278.611,091,414,192.98
  筹资活动现金流出小计1,158,536,808.44328,357,053.982,481,561,351.782,077,528,121.25
  筹资活动产生的现金流量净额-1,158,536,808.44-328,357,053.98-2,479,798,551.78-2,075,775,121.25
五、现金及现金等价物净增加额862,738,849.65422,110,454.33-547,529,426.29-171,740,181.28
  加:期初现金及现金等价物余额1,613,268,444.231,613,268,444.232,160,797,870.522,160,797,870.52
  期末现金及现金等价物余额2,476,007,293.882,035,378,898.561,613,268,444.231,989,057,689.24
补充资料:
  净利润1,069,067,642.08-1,831,025,556.6-
  资产减值准备46,632,781.15-111,612,199.85-
  固定资产和投资性房地产折旧108,751,568.08-251,570,236.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧108,751,568.08-251,570,236.59-
  无形资产摊销19,410,993.07-35,447,455.59-
  长期待摊费用摊销87,192,228.91-213,679,615.32-
  处置固定资产、无形资产和其他长期资产的损失-23,206,570.32--68,481,322.52-
  固定资产报废损失692,100.24-3,017,429.25-
  财务费用65,870,504.65-149,749,475.13-
  投资损失-56,272,544.79--124,747,936.19-
  递延所得税4,306,622.33--904,087.33-
  其中:递延所得税资产减少6,336,172.86-3,155,013.72-
    递延所得税负债增加-2,029,550.53--4,059,101.05-
  存货的减少559,364,028.87--206,446,787.59-
  经营性应收项目的减少887,071,301.8-169,264,402.32-
  经营性应付项目的增加-1,942,578,533.39--447,323,731.63-
  其他---21,777,808.7-
  现金的期末余额2,476,007,293.88-1,613,268,444.23-
  减:现金的期初余额1,613,268,444.23-2,160,797,870.52-
  现金及现金等价物的净增加额862,738,849.65--547,529,426.29-
公告日期2026-08-282026-04-232026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑